Skip to content

Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65

Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06647992
Enrollment
80
Registered
2024-10-18
Start date
2024-09-13
Completion date
2025-03-30
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancers

Keywords

Uterine Cervical Neoplasms, Patient Navigation, Transtheoretical Model, Health behavior

Brief summary

This study was designed as a randomized controlled experimental study to examine the effect of the 'Nurse Navigation Program' on cervical cancer screening behaviors (Human Papilloma Virus (HPV) DNA screening test and/or pap smear test) and health beliefs about cervical cancer screening in women aged 30-65 years.

Detailed description

An important step in the fight against cervical cancer is access to early diagnosis, early screening culture and the creation of screening opportunities. Problems in access to health services, barriers and cultural reasons play an important role in participation in cervical cancer screening. Nurse The Navigation Program is important to help individuals overcome and cope with these barriers. There are international studies showing the positive effect of the nurse navigation program on cervical cancer screening behaviors. However, it is thought that this study will contribute to the literature because the number of studies on this subject is not sufficient and no research is found in national sources. It is aimed to contribute to overcoming the problems and obstacles in front of the patients' access to cervical cancer screening with the Nurse Navigation Program application developed based on the Transtheoretical Model to the experimental group and to provide evidence for the nurse navigation program application to be a method used in the cervical cancer screening process. The population of the study will consist of female members of Non-Governmental Organizations in the 30-65 age group. The data of the study will be collected between September 13, 2024 and February 15, 2025 after ethics committee approval and institutional permission. The design of the study is a randomized controlled experimental study. The data will be collected using the Individual Descriptive Information Form, Information Questions on Reproductive Health and Sexual Life, Questions on Cervical Cancer and Screening, Questions on HPV Knowledge, Cervical Cancer and Pap Smear Test Health Belief Model Scale. The statistical data obtained as a result of the research will be analyzed using the SPSS package program. It is expected that the rate of having HPV-DNA test and Pap smear test is higher in the experimental group in which the nurse navigation program is applied compared to the control group in which the intervention is not applied, and the mean score of benefit perception of cervical cancer screening behaviors (HPV DNA and/or Pap smear) is expected to be significantly different in the group in which the nurse navigation program is applied compared to the group in which it is not applied.

Interventions

BEHAVIORALNurse Navigation Program

It is planned to provide "Cervical Cancer Education and Counseling" to women in the experimental group about cervical cancer. Training and counseling is planned to be implemented face to face. An information booklet will be given to the experimental group. After 30 and 60 days after the training and counseling given to the experimental and control groups, it was planned to provide online (WhatApp) training and counseling to the patients in the experimental group: Participants will be given a contact number that they can reach during the day when they want to receive counseling about HPV-DNA or Pap smear. Interviews will be scheduled between 08.00-20.00. Individuals who are not screened will receive a reminder message by phone on the 45th and 75th day. Transtheoretical Model In the study, interventions will be planned for the experimental group according to the stages of the transtheoretical model. The researcher will conduct motivational interviews with the individuals.

Sponsors

TURKAN OZDAS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Women aged between 30 and 65 years, able to use the WhatsApp application, not undergoing regular cervical cancer screening, with no history of gynecological cancer, currently or previously sexually active, and voluntarily willing to participate in the study.

Exclusion criteria

Women who had a current diagnosis or history of gynecological cancer, were undergoing regular cervical cancer screening, were unable to use the WhatsApp application, had never been sexually active, or did not provide voluntary consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testingPre-test, 3rd month post-test, 6th month post-testHealth Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing consists of 35 items grouped into five subscales. 1. Pap smear Benefit (items 18.-22.) and Health Motivation (items 11.-14.) subscales 2. Pap smear Perception of obstacle (items 23-36) subscale, 3. Cervical cancer severity perception (Items 4-10) subscale, 4. Cervical cancer sensitivity perception (Items 1 - 3) subscale, 5. Health Motivation subscale (items 15-17) A 5-point Likert scale ranging from 1 to 5 - "strongly disagree" (1), "disagree" (2), "undecided" (3), "agree" (4), "strongly agree" (5) - was used to assess the scale. Each dimension of the scale is evaluated separately and not combined into a single total score. For each individual, as many points are obtained as the number of sub-dimensions.

Countries

Turkey (Türkiye)

Contacts

PRINCIPAL_INVESTIGATORTurkan Ozdas

Saglık Bilimleri University

STUDY_DIRECTORDonmez Elif

Saglık Bilimleri University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026